A detailed history of Regentatlantic Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Regentatlantic Capital LLC holds 440,788 shares of PFE stock, worth $11.6 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
440,788
Previous 450,439 2.14%
Holding current value
$11.6 Million
Previous $23.6 Million 18.33%
% of portfolio
0.58%
Previous 0.78%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $422,327 - $515,556
-9,651 Reduced 2.14%
440,788 $19.3 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $168,996 - $200,377
3,632 Added 0.81%
450,439 $23.6 Million
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $275,964 - $341,954
-6,032 Reduced 1.33%
446,807 $23.1 Million
Q4 2021

Jan 27, 2022

SELL
$41.32 - $61.25 $404,481 - $599,576
-9,789 Reduced 2.12%
452,839 $26.7 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $221,370 - $284,368
5,640 Added 1.23%
462,628 $19.9 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $116,563 - $132,047
-3,246 Reduced 0.71%
456,988 $17.9 Million
Q1 2021

Apr 29, 2021

SELL
$33.49 - $37.77 $388,550 - $438,207
-11,602 Reduced 2.46%
460,234 $16.7 Million
Q4 2020

Feb 04, 2021

SELL
$33.47 - $42.56 $102,317 - $130,105
-3,057 Reduced 0.64%
471,836 $17.4 Million
Q3 2020

Oct 13, 2020

BUY
$31.75 - $37.25 $505,936 - $593,578
15,935 Added 3.47%
474,893 $17.4 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $225,448 - $273,501
7,485 Added 1.66%
458,958 $15 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $635,664 - $908,226
-23,517 Reduced 4.95%
451,473 $14.7 Million
Q4 2019

Feb 04, 2020

SELL
$32.92 - $37.36 $173,817 - $197,260
-5,280 Reduced 1.1%
474,990 $18.6 Million
Q3 2019

Oct 22, 2019

SELL
$32.49 - $42.13 $402,973 - $522,538
-12,403 Reduced 2.52%
480,270 $17.3 Million
Q2 2019

Jul 23, 2019

SELL
$36.98 - $41.52 $371,722 - $417,359
-10,052 Reduced 2.0%
492,673 $21.3 Million
Q1 2019

May 03, 2019

SELL
$37.5 - $41.2 $22,237 - $24,431
-593 Reduced 0.12%
502,725 $21.4 Million
Q4 2018

Jan 30, 2019

BUY
$38.47 - $43.86 $1.71 Million - $1.95 Million
44,571 Added 9.72%
503,318 $22 Million
Q3 2018

Oct 30, 2018

BUY
$34.47 - $41.81 $415,087 - $503,476
12,042 Added 2.7%
458,747 $20.2 Million
Q2 2018

Jul 31, 2018

BUY
$32.98 - $35.16 $614,153 - $654,749
18,622 Added 4.35%
446,705 $16.2 Million
Q1 2018

Apr 23, 2018

BUY
$31.91 - $37.02 $436,815 - $506,766
13,689 Added 3.3%
428,083 $15.2 Million
Q4 2017

Jan 23, 2018

SELL
$33.26 - $35.29 $155,523 - $165,016
-4,676 Reduced 1.12%
414,394 $15 Million
Q3 2017

Oct 25, 2017

BUY
$31.0 - $34.15 $13 Million - $14.3 Million
419,070
419,070 $15 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.